PortfoliosLab logo

Alnylam Pharmaceuticals, Inc. (ALNY)

Equity · Currency in USD · Last updated Oct 1, 2022

Company Info

ISINUS02043Q1076
CUSIP02043Q107
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$206.39
Year Range$120.42 - $233.85
EMA (50)$196.96
EMA (200)$175.85
Average Volume$1.10M
Market Capitalization$25.39B

ALNYShare Price Chart


Chart placeholderClick Calculate to get results

ALNYPerformance

The chart shows the growth of $10,000 invested in Alnylam Pharmaceuticals, Inc. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $110,342 for a total return of roughly 1,003.42%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%MayJuneJulyAugustSeptember
23.73%
-21.76%
ALNY (Alnylam Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ALNYReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-4.67%-10.05%
6M22.58%-20.85%
YTD18.03%-24.77%
1Y12.80%-17.75%
5Y11.25%7.32%
10Y26.70%9.53%

ALNYMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-18.86%14.72%3.45%-18.29%-5.72%15.94%-2.61%45.50%-3.15%
202115.78%-1.58%-4.67%-0.39%0.96%19.39%5.56%12.57%-6.27%-15.49%15.19%-7.74%
2020-0.33%2.50%-7.49%20.99%2.71%9.49%-1.59%-9.00%9.77%-15.54%5.64%0.05%
201914.57%1.76%9.94%-4.40%-24.42%7.46%6.93%4.00%-0.33%7.86%35.05%-1.68%
20182.31%-7.56%-0.88%-20.63%5.23%-0.99%-3.54%29.13%-28.65%-8.10%0.91%-10.17%
20176.81%29.13%-0.76%4.59%22.13%21.85%3.74%3.61%37.05%3.70%10.42%-5.57%
2016-26.77%-15.04%7.17%6.80%6.98%-22.63%22.69%2.60%-2.96%-47.48%23.23%-14.66%
2015-3.27%8.21%2.85%-2.44%28.68%-8.56%6.31%-19.24%-21.91%6.96%21.07%-9.53%
201430.11%-2.89%-17.36%-26.23%19.71%6.54%-14.33%28.74%12.10%18.75%8.42%-3.53%
201332.22%-1.82%2.87%-1.72%27.89%1.21%48.94%12.19%23.57%-10.00%6.23%5.07%
201241.84%15.40%-17.02%2.89%-10.10%13.77%60.43%-2.14%2.73%-13.94%4.95%7.54%
20114.72%6.34%-12.91%7.29%2.05%-10.51%0.11%-25.59%-5.87%23.59%-12.56%14.79%
2010-6.84%3.08%-2.30%-0.35%-6.84%-4.94%2.20%-10.94%-10.24%7.09%-30.37%7.76%

ALNYSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Alnylam Pharmaceuticals, Inc. Sharpe ratio is 0.09. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MayJuneJulyAugustSeptember
0.09
-0.77
ALNY (Alnylam Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ALNYDividend History


Alnylam Pharmaceuticals, Inc. doesn't pay dividends

ALNYDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-14.41%
-25.25%
ALNY (Alnylam Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ALNYWorst Drawdowns

The table below shows the maximum drawdowns of the Alnylam Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Alnylam Pharmaceuticals, Inc. is 77.36%, recorded on Nov 3, 2016. It took 257 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-77.36%Jun 23, 2015347Nov 3, 2016257Nov 10, 2017604
-67.95%Jan 12, 2010436Oct 3, 2011197Jul 16, 2012633
-57.81%Mar 21, 2018193Dec 24, 2018374Jun 19, 2020567
-47.61%Jan 14, 201472Apr 28, 2014126Oct 24, 2014198
-42.46%Oct 15, 2021144May 11, 202257Aug 3, 2022201
-27.49%Sep 18, 201236Nov 8, 201246Jan 16, 201382
-26.79%Jan 26, 202173May 10, 202128Jun 18, 2021101
-26.77%Jul 21, 202037Sep 10, 202085Jan 12, 2021122
-23.21%Oct 3, 201331Nov 14, 201325Dec 20, 201356
-19.72%Dec 10, 201438Feb 4, 201514Feb 25, 201552

ALNYVolatility Chart

Current Alnylam Pharmaceuticals, Inc. volatility is 41.40%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%MayJuneJulyAugustSeptember
41.40%
19.40%
ALNY (Alnylam Pharmaceuticals, Inc.)
Benchmark (^GSPC)